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Abstract
Background: Tetratricopeptide repeat (TPR) motif containing co-chaperones of the chaperone Hsp90 are considered
control modules that govern activity and specificity of this central folding platform. Steroid receptors are paradigm clients of
Hsp90. The influence of some TPR proteins on selected receptors has been described, but a comprehensive analysis of the
effects of TPR proteins on all steroid receptors has not been accomplished yet.
Methodology and Principal Findings: We compared the influence of the TPR proteins FK506 binding proteins 51 and 52,
protein phosphatase-5, C-terminus of Hsp70 interacting protein, cyclophillin 40, hepatitis-virus-B X-associated protein-2,
and tetratricopeptide repeat protein-2 on all six steroid hormone receptors in a homogeneous mammalian cell system.
To be able to assess each cofactor’s effect on the transcriptional activity of on each steroid receptor we employed
transient transfection in a reporter gene assay. In addition, we evaluated the interactions of the TPR proteins with the
receptors and components of the Hsp90 chaperone heterocomplex by coimmunoprecipitation. In the functional assays,
corticosteroid and progesterone receptors displayed the most sensitive and distinct reaction to the TPR proteins.
Androgen receptor’s activity was moderately impaired by most cofactors, whereas the Estrogen receptors’ activity was
impaired by most cofactors only to a minor degree. Second, interaction studies revealed that the strongly receptor-
interacting co-chaperones were all among the inhibitory proteins. Intriguingly, the TPR-proteins also differentially co-
precipitated the heterochaperone complex components Hsp90, Hsp70, and p23, pointing to differences in their modes
of action.
Conclusion and Significance: The results of this comprehensive study provide important insight into chaperoning of
diverse client proteins via the combinatorial action of (co)-chaperones. The differential effects of the TPR proteins on steroid
receptors bear on all physiological processes related to steroid hormone activity.
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Introduction
Steroid hormones are lipophilic signalling molecules, mediating
a vast variety of physiological effects that depend on the cellular
context of the target tissue. They act via steroid hormone receptors
(SR), which belong to the nuclear receptor superfamily of ligand-
activated transcription factors and serve as regulators of various
target genes [1–3]. Upon binding to hormone, SR accumulate in
the nucleus and either enhance or decrease transcription by
interacting with their cognate DNA elements or by ‘‘cross-talk’’
with other transcription factors [4–6].
Hormone binding and activity of SR is shaped by molecular
chaperones [7]. In general, molecular chaperones are highly
conserved and abundant proteins that change the folding energy
landscape for their client proteins to assist them in reaching their
native conformation in an efficient and timely manner [8,9]. SR
interact with a heterocomplex consisting of the heat shock protein
(Hsp) 90, Hsp70, Hsp40, Hsp70/Hsp90 organizing protein (HOP),
p23 and various cochaperones in a stepwise fashion to attain a
conformational state competent of binding to hormone with high
affinity [10]. The model that emerged from research over the last
two decades states that the initial folding steps are aided by Hsp70
based chaperones and co-chaperones, while the final steps are
expedited through Hsp90-centred heterocomplexes [11].
Both Hsp70 and Hsp90 feature a C-terminal EEVD motif that
serves as acceptor site for cochaperones that harbour a
tetratricopeptide repeat (TPR) domain [12]. In particular the
Hsp90-interacting TPR proteins have received broad attention as
proposed regulators of SR function [11,13]. Among these TPR
proteins are the carboxyl terminus of Hsc70-interacting protein
(CHIP), Cyclophillin-40 (Cyp40), the immunophilin FK506-
binding proteins (FKBP) 51 and 52, protein phosphatase 5
(PP5), the tetratricopeptide repeat protein 2 (TPR2) and the
hepatitis virus B X-associated protein 2 (XAP2).
Many of the TPR proteins bring additional molecular functions
to the SR-chaperone heterocomplexes. CHIP contains a C-
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and has been reported to promote degradation of various steroid
receptors [14–17]. The immunophilin and peptidylprolyl isomer-
ase (PPIase) Cyp40 has also been identified in SR-heterocom-
plexes, but its role regarding SR-function is still unclear [18].
FKBP51, another PPIase, was characterised as a cellular factor
contributing to the glucocorticoid resistance observed in New
World primates [19,20]. It inhibits glucocorticoid receptor (GR)
activity by lowering hormone binding affinity of the receptor and
delaying nuclear translocation [20,21], and also inhibits the
mineralocorticoid receptor [22]. In contrast, the highly homolo-
gous FKBP52 was found to positively modulate SR function
and to be critical for progesterone and androgen function
in vivo [18,23–27]. While the PPIase protein domains of FKBP51
and FKBP52 play an important role in GR’s regulation, the
function of the enzymatic PPIase activity remains enigmatic
[18,21,28].
PP5 is the only TPR-domain containing phosphatase identified
so far; it has been shown to modulate a variety of cellular
pathways [29]. The role of PP5 in SR signalling appears
controversial so far, possibly due to the different approaches
and experimental systems. Both positive and negative modulatory
effects of PP5 on steroid dependent transcription have been
reported. Down-regulation of PP5 expression was shown to
increase GR activity in reporter gene assays [30] and transcrip-
tion of estrogen receptor (ER) target genes [31] suggesting a
negative modulatory role of PP5 in steroid dependent signalling.
In contrast, in a different study siRNA-mediated PP5 knock-
down lead to a decrease in transcription of GR target genes [32].
In yeast, the PP5 homolog Ppt1 acts as a positive modulator of
GR, possibly by removing inhibitory phosphates from Hsp90
[33].
TPR2 is a J-domain containing cochaperone which has been
demonstrated to modulate GR and PR signalling [34,35]. It may
act by mediating the retrograde transfer of substrates from Hsp90
onto Hsp70 [34]. XAP2 has been well studied for its role in
regulating the activity of the arylhydrocarbon receptor (AhR) class
of nuclear receptors [36]. Recently, XAP2 was shown to inhibit
GR-mediated transcription [37].
Based on evidence from the literature and our own studies on
the GR-inhibitory role of FKBP51, we had initiated a genotyping
study that revealed a genetic association of this TPR protein with
the response to medication in major depression [38]. Meanwhile,
FKBP51 has been included in several studies and attracted great
attention for the association of its genetic polymorphisms and gene
expression level with a number of stress-related phenotypes and
neuropsychological diseases, such as major depression or post
traumatic stress disorder [38–46]. All these findings corroborate a
physiological role of FKBP51 in stress regulation, most likely via its
action in GR signalling.
Since several TPR proteins should be able to compete with
FKBP51 for binding to the binding site for TPR proteins in an
Hsp90 dimer [47–49], we assume that the overall impact of
FKBP51, or any other TPR protein, on GR, or SR in general,
depends on the relative abundance and mode of action of the
other TPR proteins present in the same cell. Knowledge about
each of these factors’ capability to influence SR function might
provide the basis for the understanding of tissue responsive-
ness to steroid hormones. A comprehensive comparison of the
TPR-proteins on the function of all steroid receptors in a
homogenous mammalian system has not been accomplished yet.
Thus, we assessed the impact of the TPR proteins CHIP,
Cyp40, FKBP51, FKBP52, PP5, TPR2 and XAP on each of
the SR.
Results
Different responsiveness of the steroid hormone
receptors in reporter gene assay
To set up an assay for the determination of the influence of the
seven selected TPR proteins CHIP, CYP40, FKBP51, FKBP52,
PP5, TPR2 and XAP2 on the six steroid receptors GR, MR, PR,
AR, ERa and ERb, we established reporter gene assays for each of
the receptors. For GR, MR, PR and AR, we made use of the
hormone-responsive elements of the MMTV LTR promoter that
was linked to the structural part of the firefly luciferase gene [50].
To measure the activity of the two ER receptors we used a
luciferase reporter plasmid with two copies of an estrogen
responsive element instead of the MMTV LTR [51]. For each
receptor, we used two sub-saturating concentrations of hormone as
well as one concentration well in the range of saturation.
GR and PR displayed the widest, AR a considerable, and MR
and the two ERs a moderate range of hormone inducible activity
in human neuronal SK-N-MC cells (Fig. 1). We chose this cell line
for two reasons, first because is largely devoid of steroid receptors,
and second because of its neuronal origin.
Since the effects of FKBP51 on GR have been reported to be
most pronounced at sub-saturating concentrations of hormone, we
focused our further analyses on conditions that yielded significant,
but not yet full activation of the respective steroid receptor. In
addition, we also included one saturating concentration of
hormone for each receptor.
Steroid receptors display differential sensitivity to TPR-
proteins
To assess the effect of the TPR proteins on steroid receptor
activity, each of the FLAG-tagged TPR proteins was co-expressed
with each of the HA-tagged steroid receptors GR, MR, PR, AR,
ERa,o rE R b, respectively, along with reporter and control
plasmids. Since mammalian cells, in contrast to yeast, feature a
number of different receptor-relevant TPR proteins, we reasoned
that overexpression of a specific TPR protein is necessary to
significantly enhance occupancy of the TPR acceptor site on
Hsp90 by this specific cofactor. To test whether this is indeed the
case under the conditions chosen we first evaluated the degree of
overexpression for each of the TPR cofactors (Fig. 2A). Cells were
transfected with plasmids encoding for one of the TPR proteins
and probed their abundance in cell lysates using Western blot
analysis. Each of the TPR cofactors was at least 4 fold enhanced
over the endogenous levels (Fig. 2A).
Since our experimental design was further based on the
assumption that selectively enhancing the level of one of the
TPR cofactor results in changing the composition of the Hsp90
heterocomplexes, we tested this at the example of FKBP52
overexpression. Cells were transfected with FKBP52 expressing
plasmid, and Hsp90 complexes were immunoprecipitated from
cell lysates of FKBP52 overexpressing cells and control cells. While
more FKBP52 was co-precipitated with Hsp90 complexes, all the
other investigated TPR cofactors were less abundant (Fig. 2B,
Cyp40 was below detection limit). As an important control, the
interaction of Hsp90 with the non TPR protein p23 was not
changed by increasing FKBP52 (Fig. 2B).
The first observation we made in the reporter gene assays was
that, in general, the changes in receptor activity upon co-
expression of TPR cofactors were more pronounced for GR,
MR, and PR than for AR, and even more than for the two ERs,
which were almost not affected (Figs. 3 and 4). Strong inhibitors of
GR were CHIP, FKBP51, PP5, TPR2, and XAP2, while CYP40
and FKBP52 showed virtually no effect (Fig. 3A). As shown for
TPR Proteins Influence SR
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was greatly diminished, even though TPR2, for example, still
reduced GR’s activity twofold (Fig. 3B). Similar observations were
made with saturating concentrations of hormone at the other
receptors (data not shown).
The TPR reactivity profile of MR was very similar, except for
PP5 and XAP, which exerted only a marginally inhibitory effect
on MR (Fig. 3C). Albeit we were using stripped serum free of
steroids, we observed a significant activity of MR even in the
absence of added hormone, which was affected by the TPR
cofactors in the same way as the hormone-stimulated activity
(Fig. 3C and data not shown). To test whether any serum
component might have contributed to hormone-independent
activation of MR we cultivated transfected cells in serum free
media for 24 h before measuring reporter activity. Serum
withdrawal reduced MR-dependent transactivation, suggesting
that factors other than glucocorticoids are present in steroid free
media which partially activate MR’s transcriptional activity
(Fig. 3D). This effect appeared to be additive to the glucocorti-
coid-mediated effect, because stimulation with sub-saturating
concentrations of fludrocortisol (0.03 nM) in stripped serum
containing media resulted in higher MR activation than in serum
free media (Fig. 3D).
Similarly to GR, PR showed the highest activity when co-
expressed together with CYP40 or FKBP52 (Fig. 4A). The effects
of the TPR-cofactors were noticeably attenuated in the case of AR
(Fig. 4B). Only co-expression of FKBP52 maintained AR activity,
while all the other TPR cofactors reduced this receptor’s activity to
a moderate degree, with TPR2 being the strongest inhibitor (5 fold
inhibition, Figure 4B). ERa and ERb showed almost no reaction
to the presence of TPR cofactors under our conditions, except for
TPR2, which reduced the activity of these receptors about 2 fold
(Figs. 4C, D).
We also monitored the expression levels of the co-expressed
receptors and TPR proteins. There were some variations
throughout the experiments, but overall there were no gross
alterations in the levels of the steroid receptors in dependence of
the co-expressed TPR cofactor, except for CHIP which often,
albeit not consistently, led to lower receptor expression levels
(Figs. 3 and 4 examples in the panels below the activity assay
graphs). This was not unexpected, because CHIP has been
identified as E3 ligase and been shown to reduce the levels of GR
[15]. The levels of the co-expressed TPR proteins also varied
between experiments. Overall, Cyp40 and TPR2 had a tendency
to be expressed at lower levels, and to a lesser extent also FKBP51,
while the other cofactors expressed at the same levels.
The estrogen receptors show little sensitivity to
geldanamycin
Since most of the TPR proteins had little impact on ERs’
transcriptional activity, we wondered whether these two receptors
are dependent on functional Hsp90 at all under our assay
Figure 1. Response of steroid hormone receptors in MMTV-reporter gene assays. Neuronal SK-N-MC cells were transfected with a plasmid
expressing one of the HA-tagged SRs, the MMTV firefly-luciferase reporter plasmid when transfecting GR, MR, PR, or AR, an ERE firefly-luciferase
reporter plasmid for ERa and ERb, and the Gaussia-KDEL control plasmid. After transfection, the cells were cultivated for 24 h in the presence of the
indicated concentrations of hormone (DHT: Dihydrotestosterone) or EtOH as solvent control. Receptor activity represents firefly data normalized to
Gaussia activities + S.E.M. of at least four independent experiments, each performed in duplicate.
doi:10.1371/journal.pone.0011717.g001
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geldanamycin (GA), which has been shown to block Hsp90 activity
by binding to its ATP pocket [52,53]. We performed reporter gene
assays for ERa,E R b, and GR in the presence or absence of GA
(Fig. 5). While GA efficiently reduced the activity of GR (Fig. 4C),
it had very little effect, if any, on the activity of ERa and ERb
(Figs. 5A,B). Whatever the reason for the apparent Hsp90-
independent action of these two receptors is, it could explain why
the Hsp90 cofactors have so little impact on their activity.
It has been found that GA leads to degradation of Hsp90 client
proteins such as GR [54–56]. To test whether the differential
responsiveness of GR and ER to GA is also reflected on the level of
protein stability, we measured the expression levels of GR and ER
upon GA treatment. Neither GR nor ER were significantly
changed in their protein levels after exposure of transfected HEK
cells (Fig. 5) or SK-N-MC cells (data not shown) with GA, which
could be due to the much lower concentrations of GA used here
compared to other studies [54,55].
Cyclophilin 40 is unable to rescue receptor activity
FKBP52, which does not change the activity of GR when co-
expressed with this receptor in mammalian cells (Fig. 3A, and
[21]), has been shown to be able to attenuate the inhibitory effect
of FKBP51 [21]. In our screen of the activity profiles of the TPR
proteins Cyp40, like FKBP52, had no or very little effect on steroid
receptors (Figs. 3 and 4). Thus, the question arose, whether an
effect of Cyp40 on GR or MR may become apparent under
conditions of compromised receptor activity, i.e. when an
inhibitory protein is co-expressed. Therefore, we coexpressed
FKBP51 at moderate levels to inhibit GR and MR, and added
increasing amounts of Cyp40 expressing plasmid (Fig. 6). Even
though Cyp40 was expressed up to levels that exceeded those of
FKBP51 (both proteins were FLAG tagged, allowing a direct
comparison in a Western blot) and well above endogenous levels, it
was unable to rescue the activity of GR or MR (Figs. 6A and B).
This is in contrast to FKBP52, which has been shown to be able to
revert the inhibitory action of FKBP51 [21].
Figure 2. TPR proteins are significantly enhanced upon ectopic expression and change Hsp90 heterocomplex composition. A, SK-N-
MC cells were transfected with plasmid expressing one of the TPR proteins, lysed after 48 h and levels of the respective TPR protein was determined
by Western blot analysis. B, HEK-293 cells were transfected with FLAG tagged Hsp90 along with FKBP52 expressing plasmid or control plasmid. Hsp90
was precipitated from lysates and the levels of co-precipitated cofactors were determined by Western blot.
doi:10.1371/journal.pone.0011717.g002
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Hsp90 heterocomplexes
The ability of TPR proteins to access heterocomplexes of steroid
receptors and Hsp90 is assumed as prerequisite for their impact on
these receptors. Therefore, we evaluated the relative incorporation
of the TPR-proteins into steroid receptor complexes employing
complementary co-immunoprecipitation. The estrogen receptors
were not included, because they were only marginally affected by
most of the TPR proteins. We expressed each of the HA-tagged
steroid receptors in combination with each of the seven FLAG-
tagged TPR proteins and performed co-immunoprecipitations
with antibodies directed against the HA-tagged receptors or the
FLAG-tagged TPR proteins, respectively, and visualized co-
precipitated proteins by Westernblot analysis.
Figure 3. GR and MR activities in the presence of different TPR-proteins. A-C, SK-N-MC cells in 96 well plates were transfected with the
MMTV-Luc, Gaussia-KDEL control plasmid, a plasmid expressing one of the HA-tagged steroid hormone receptor (GR in A and B, MR in C and D) and
constant amounts (200 ng) of a plasmid expressing one of the FLAG-tagged TPR-proteins. After transfection, the cells were cultivated for 24 h in the
presence of hormone or vehicle as indicated. Relative receptor activity represents firefly data normalized to Gaussia activities and presented as
relative stimulation to control + S.E.M. of at least four independent experiments performed in duplicate. Control cells were transfected with cloning
plasmid instead of the TPR protein expressing plasmid. Lower panels of A and C, immunoblot of cell extracts, probed with anti-HA antibody
visualizing steroid receptor expression, the same membrane probed with FLAG antibody demonstrating expression of TPR proteins and with actin
antibody as loading control. D, After transfection, cells were cultivated in 0.1% or 10% SF-FCS containing media for 24 h in the presence of 0.03 nM
fludrocortisol, or EtOH as vehicle control. Firefly luciferase data were normalized to Gaussia luciferase activities and are presented as relative
stimulation + S.E.M. of three independent experiments performed in triplicate. * denotes p-values #0.001.
doi:10.1371/journal.pone.0011717.g003
TPR Proteins Influence SR
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andARassays),ortheERE-Lucreporterplasmid(forERaandERbassays),theGaussia-KDELcontrolplasmid,aplasmidexpressingtheHA-taggedsteroidhormone
receptor as indicated and the plasmid expressing a FLAG-tagged TPR-protein. After transfection, cells were cultivated for 24 h in the presence of hormone as
indicated. Relative receptor activity represents firefly data normalized to Gaussia activities and presented as relative stimulation to control +S.E.M. of at least four
independent experiments performed in duplicate. Control cells were transfected with cloning plasmid replacing the TPR protein expression plasmid in the
transfection mixture. Lower panels of A–D display immunoblots of cell extracts, probed with anti-HA antibody visualizing steroid receptor expression, the same
membrane probed with FLAG antibody demonstrating expression of the TPR proteins and with actin antibody as loading control. * denotes p-values #0.001.
doi:10.1371/journal.pone.0011717.g004
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precipitated protein using HA- or FLAG-directed antibodies, co-
precipitated proteins were normalized to the precipitated primary
target, and in case of HA-directed IPs also to the relative
expression of the different TPR proteins.
For GR, the receptor IP revealed CHIP, FKBP51 and TPR2 as
strong binders to the heterocomplex (Fig. 7). The FLAG-IPs
targeting the TPR proteins revealed a similar binding pattern. We
observed that Cyp40 exhibited weak interaction with the
heterocomplex, which may account for its inability to compete
the inhibitory effect of FKBP51. Notably, the strongest binders all
were strongly inhibitory proteins. On the other hand, PP5, which
also significantly reduced GR activity, in comparison displayed
only moderate interaction.
For MR, the interaction pattern of the TPR cofactors was
similar to that of GR. Again, CHIP, FKBP51 and TPR2 exhibited
strong interaction, while Cyp40 showed very little binding, both
when immunoprecipitating the receptor or the cofactor (Fig. 8 A
and B). Of note, the inability of PP5 to inhibit MR’s
transcriptional activity was not reflected by a corresponding low
incorporation into MR heterocomplexes.
In the case of PR, we observed the strongest interaction with the
PR-Hsp90 heterocomplex for CHIP, FKBP51, and TPR2 (Fig. 9),
which in the reporter gene assay also were the ones that exhibited
the strongest inhibitory activity (Fig. 4A). Remarkably, XAP2 and
PP5, which also reduced PR’s transcriptional activity, bound only
weakly to the complex.
Although AR showed less activity change in response to co-
expression of TPR cofactors than GR, MR and PR, the TPR
cofactors exhibited a distinct binding profile (Fig. 10). The most
efficient binding was observed for TPR2, in the presence of which
AR was least transcriptionally active (Fig. 4B). In general though,
there was no strict correlation between binding efficiency to the
Hsp90-AR heterocomplex and the influence on the transcriptional
activity of AR. For example, in the presence of CHIP or Cyp40,
AR exhibited a very similar transcriptional activity, but these two
TPR proteins differed markedly in their ability to access the AR-
Hsp90 heterocomplex (Figs. 4B and 10).
TPR cofactors favor differently composed multi-
chaperone heterocomplexes
During maturation, the steroid receptor proceeds through a
multi-chaperone machinery in which each step is characterized by
a relative abundance of distinct chaperones [7]. Therefore, it is
possible that preference of the TPR cofactors to distinct
heterochaperone complex compositions represents an important
mechanistic aspect of their function. Thus, we compared the
abundance of endogenous components of the chaperone machin-
ery co-precipitating with the immunoadsorbed TPR-cofactors.
Since the FLAG-tagged proteins were precipitated with
different efficiencies (although amounts of plasmids were adjusted
so that the TPR proteins were expressed at similar levels, compare
Figs. 7–10), the amount of co-precipitated Hsp90, Hsp70 and p23
was normalized to the amount of precipitated TPR cofactor. We
consistently observed some nonspecific binding of Hsp70 to the
FLAG agarose resin, and therefore, considered only levels
exceeding the background binding as indicative of Hsp70
interaction. Co-expression of the different steroid receptors did
not change the relative co-precipitation of Hsp70, Hsp90 and p23.
Therefore, we used the results of experiments with different steroid
receptors to determine the relative binding of these components to
the TPR-proteins.
Hsp90 interaction was detected for all TPR cofactors investi-
gated here, as expected. However, there was a considerable
difference in the relative amount of co-precipitated Hsp90
(Fig. 11A and B). FKBP51 and FKBP52 displayed the strongest
Hsp90 interaction, and PP5 still about 4 fold higher interaction
than CHIP, CYP40, TPR2 and XAP2, which all bound at
comparable levels. Notably, while p23 interaction reflected the
relative Hsp90 co-precipitation in general, p23 co-precipitated
with FKBP52 less than with FKBP51 or PP5 in relation to the
Hsp90 association (Fig. 11C). Apparently, FKBP51 and PP5 favor
p23 containing Hsp90 heterocomplexes more than FKBP52,
possibly by stabilizing the interaction between Hsp90 and p23.
Hsp70 binding was detected for CHIP and TPR2, as reported
previously [34,57]. No Hsp70 binding was detected for CYP40,
FKBP52, PP5 and XAP2, but surprisingly, for FKBP51. Although
Figure 5. Estrogen receptors display little sensitivity to the Hsp90 inhibitor geldanamycin. SK-N-MC cells were transfected with 0.25 mg
of one of the plasmids expressing ERa (A), ERb (B) or GR (C), together with either ERE-Luc (A,B) or MMTV-Luc (C) as reporter plasmid and the Gaussia-
KDEL control plasmid. After transfection, the cells were cultivated for 24 h in the presence of hormone and 10 ng/ml GA as indicated. Relative
receptor activity represents Firefly data normalized to Gaussia activities and is presented as relative stimulation to control + S.E.M. of at least four
independent experiments performed in duplicate. Lower panels, analysis of receptor expression after GA treatment in the presence or absence of
hormone (10 nM estrogen, 500 nM cortisol).
doi:10.1371/journal.pone.0011717.g005
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TPR2, it was significantly more than the virtually non existent
Hsp70 binding of FKBP52 (p=0.007 in an unpaired student’s t-
test). This could indicate that FKBP51 favors early stages of the
folding cycle, which could contribute to its inhibitory function.
Loss of FKBP52 impairs GR function
The experiments described so far were based on increasing the
abundance of a specific TPR cofactor in Hsp90 heterocomplexes.
Considering the plethora of TPR cofactors in the cell, we
pondered on the ability of mammalian cells to compensate for
the loss of one of the proteins. Based on the inability of enhanced
FKBP52 to significantly increase GR function, we reasoned that
loss of an inhibitory factor, for example FKBP51, would have little
effect. Therefore, we experimentally addressed the effect of loss of
the established positive GR regulator FKBP52. Since our attempts
to reduce FKBP52 using si-RNA resulted in only partial reduction
(data not shown), we used mouse embryonic fibroblast (MEF)
FKBP52 KO and WT cells. We found that stimulation of GR
activity at saturating concentrations of hormone was not
significantly affected (data not shown). However, higher concen-
trations of hormone were needed in FKBP52 ko cells to elicit a GR
response comparable to that in WT MEF cells (Fig. 12).
Since cells derived from different animals and cultivated for
several generations can differ in numerous factors, it was
mandatory to test whether the difference in the cortisol
responsiveness between WT and FKBP52 KO MEF cells was
indeed due to loss of FKBP52. Therefore, we overexpressed
FKBP52 in FKBP52 KO MEF cells, which rendered the cortisol
responsiveness indistinguishable from that of WT MEF cells
(Fig. 12).
Discussion
How are molecular chaperones able to assist correct folding of a
plethora of structurally divergent proteins? In general, the various
chaperone factors protect non-native protein chains from
misfolding and aggregation, but do not contribute conformational
information to the folding process [8]. They interact with features
of non-native protein folds that are common to many proteins,
such as hydrophobic stretches and unstructured backbone regions,
and provide nano-compartments to shield proteins during their
folding process from other proteins. Hsp90 regulates mainly a wide
range of signal transduction molecules, and thus belongs to the
more specialised, but still very versatile chaperones [9,58]. Our
study provides a better understanding of this versatility through
combinatorial compositions of the Hsp90-client heterocomplexes.
Of the six steroid receptors, the closely homologous GR, MR
and PR exhibited the strongest reaction to changes in the TPR-
protein make-up of the cell (Fig. 2 and 3). AR, and the ERs in
particular, were less affected by co-expressing any of the co-
chaperones. This may be explained by a diminished Hsp90-
dependency of ER, at least in our cellular set-up, corroborated by
the ineffectiveness of GA towards ER. Others have also provided
evidence that ER may operate independently of Hsp90 [59,60],
which contrasts reports on lower ER activity where Hsp90
function was compromised [61–64]. It should be noted, though,
Figure 6. Cyp 40 is unable to compete the inhibitory effect of
FKBP51. SK-N-MC cells were transfected with the MMTV-Luc reporter
plasmid, the Gaussia-KDEL control plasmid, one of the plasmids
expressing the HA-tagged GR or MR as indicated, and plasmids
expressing FKBP51 and Cyp40 at the indicated amounts. After
transfection, the cells were cultivated for 24 h in the presence of
10 nM cortisol (A) or 0.03 nM Fludrocortisol (B). Bar graphs indicate the
relative reporter activity representing Firefly measurements normalized
to Gaussia activities and presented as relative stimulation + S.E.M. of
three independent experiments performed in triplicate. Lower panel of
A displays immunoblots of cell extracts, probed with HA antibody
demonstrating GR expression and the same membrane probed with
FLAG antibody to detect overexpressed FKBP51 and Cyp40, and actin as
control. In addition, antibodies directed against FKBP51 or Cyp40 were
used to visualize the combined levels of endogenous and ectopic TPR
protein.
doi:10.1371/journal.pone.0011717.g006
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PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11717Figure 7. TPR-proteins differently interact with GR heterocomplexes. HEK-293 cells were transfected with 5 mg of a plasmid expressing HA-
tagged GR together with 2-10 mg (to achieve similar expression levels) of one of the plasmids expressing a FLAG-tagged TPR protein. After 48-72 h
cultivation in SF-FCS containing media, cells were harvested, lysed, and protein extracts prepared for immunoprecipitation of either the HA-tagged
GR (A), or the FLAG-tagged TPR-proteins (B). A, Precipitation of HA-GR. Displayed is an example of an immunoblot that was probed with FLAG
antibody to visualize co-precipitated TPR-proteins (upper right panel), and an immunoblot of the same membrane probed with HA antibody
demonstrating precipitated GR (lower right panel). Left panel, quantification of the relative binding of the TPR-proteins to the steroid receptor
heterocomplexes. FLAG- and HA-immunoblot signals of the eluates and FLAG immunoblot signals of the cell extracts, demonstrating expression of
TPR proteins (C), were scanned and subjected to densitometry. The signal from the co-precipitated FLAG protein was corrected first by the amount of
precipitated receptor and second by the amount of the TPR-protein present in the respective cell extract. Binding of TPR-proteins is presented
relative to the mean of the normalized FLAG-eluate signals of CHIP, FKBP51, FKBP52, and PP5. Quantification represents the means of three
independent experiments +S.E.M. B, precipitation of TPR proteins. Upper right panel, coomassie stained gel of eluates visualizing precipitated TPR-
proteins (arrowheads) and co-precipitated Hsp90 and Hsp70. Lower right panel, immunoblots of eluates probed with HA antibody to demonstrate
binding of GR to TPR-protein heterocomplexes. Left panel, quantification of the relative binding of co-precipitated proteins to the precipitated TPR-
proteins. For quantification, signals were scanned and subjected to densitometry. Each HA immunoblot signal of the eluate was corrected by the
amount of precipitated TPR-protein. Binding of steroid receptors is presented relative to the mean of the corrected HA eluate signals. Quantifications
represent means of three independent experiments +S.E.M.
doi:10.1371/journal.pone.0011717.g007
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reports. We used a 20–100 fold lower concentration of GA, which
efficiently reduced GR activity, like we also have observed
previously [65]. We cannot exclude the possibility that ER activity
could be impaired also in our cellular system at very high
concentrations of GA, which however, would raise the question of
non-specific effects of GA. We propose that the Hsp90-
dependency of ER is cell-type dependent, and possibly affected
by the presence or absence of additional, yet to be revealed factors.
In addition, high doses of GA have been reported to induce
reactive oxygen species in cells [66–69], which might contribute to
differences in the effects of GA on ER at different concentrations.
Our study also documents numerous differences in the efficacies
of the TPR proteins’ influence on SR. Cyp40 exhibited only a
minor effect on AR and PR, and no effect on GR, MR and the
ERs, which concurs with its small binding affinity to Hsp90 and
Figure 8. Differential interaction of TPR-proteins with MR heterocomplexes. HEK-293 cells were transfected as described for figure 7,
except that HA-MR was expressed instead of HA-GR. Cells were processed and protein interactions were analyzed also as described for figure 7. In A,
binding of TPR-proteins is presented relative to the mean of the normalized FLAG-eluate signals of CHIP, FKBP51, FKBP52 and PP5. Quantification
represents means of three independent experiments (two for TPR2) +S.E.M.. In B, binding is normalized as in figure 7. C, FLAG- and HA-immunoblot
signals of the cell extracts, demonstrating expression of TPR proteins and MR. Quantifications represent means of three independent experiments
+S.E.M.
doi:10.1371/journal.pone.0011717.g008
TPR Proteins Influence SR
PLoS ONE | www.plosone.org 10 July 2010 | Volume 5 | Issue 7 | e11717steroid receptor heterocomplexes in comparison to other TPR
proteins (Fig. 6–10). Work in yeast, which expresses the two Cyp40
homologues Cpr6 and Cpr7, revealed an involvement of Cpr7,
but not Cpr6 in the hormone-dependent activity of GR [70,71]. In
addition, Cpr6 did not influence Hsp90 activity [72]. In
mammalian cells, the effect of Cyp40 on steroid receptors has
not been directly assessed. However, cyclosporine A, which is
known to target Cyp40 as well as Cyp18, somewhat diminished
AR function in LNCaP cells [73].
CHIP efficiently inhibited the transactivational activity of GR,
MR, PR, and moderately affected AR. It has been reported that
CHIP induces degradation of GR, AR and ERa [15–17] and
reduces hormone binding of GR [15]. With respect to steroid
receptor degradation, we observed a tendency towards lower
receptor amounts, but no consistently significant effect. Since
saturating concentrations of hormone greatly attenuated the
inhibitory effect of CHIP on all steroid receptors (Fig. 2B for
GR and data not shown for MR, PR, AR), mechanisms in
Figure 9. Differential interaction of TPR-proteins with PR heterocomplexes. HEK-293 cells were transfected as described for figure 7, except
that HA-MR was expressed instead of HA-GR. Cells were processed and protein interactions were analyzed also as described for figure 7. In A, binding
of TPR-proteins is presented relative to the mean of the normalized FLAG-eluate signals of CHIP, FKBP52, PP5 and TPR2. Quantification represents
means of three independent experiments (two for FKBP51) +S.E.M. In B, binding is normalized as in figure 7. C, FLAG- and HA-immunoblot signals of
the cell extracts, demonstrating expression of TPR proteins and PR. Quantifications represent means of three independent experiments +S.E.M.
doi:10.1371/journal.pone.0011717.g009
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observed inhibition, most likely reduction of hormone binding.
Moreover, the interaction of CHIP with Hsp70 may lead to an
influence on SR at early stages of the folding cycle, similarly to
TPR2 [34]. AR may be a special case, as CHIP interacts not only
via Hsp90 with the LBD of this receptor, but also via its C-
terminus with a conserved motif at the N-terminus of the receptor
[17].
Increasing or reducing the levels of TPR2 has been shown to
reduce the activity of GR and PR [34,35], while other steroid
receptors had not been analyzed before. In our experiments,
increased levels of TPR2 resulted in a strong reduction of the
activity of all SR, in contrast to the other investigated TPR
proteins, which exhibited at least some selectivity in their action on
SR. Our finding of strong interaction of TPR2 with Hsp70, but
only moderate interaction with Hsp90 in comparison with other
TPR proteins, supports the hypothesis that TPR2 acts by
interference at early stages of the SR folding cycle [34,35].
Furthermore, TPR2 still displayed considerable inhibitory activity
at saturating conditions of hormone. Thus, TPR2 most likely
Figure 10. Differential interaction of TPR-proteins with AR heterocomplexes. HEK-293 cells were transfected as described for figure 7,
except that HA-MR was expressed instead of HA-GR. Cells were processed and protein interactions were analyzed also as described for figure 7. In A,
binding of TPR-proteins is presented relative to the mean of the normalized FLAG-eluate signals of CHIP, FKBP51, and TPR2. Quantification represents
means of three independent experiments (two for XAP2) +S.E.M. In B, binding is normalized as in figure 7. C, FLAG- and HA-immunoblot signals of the
cell extracts, demonstrating expression of TPR proteins and AR. Quantifications represent means of three independent experiments +S.E.M.
doi:10.1371/journal.pone.0011717.g010
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binding affinity [34].
For XAP2, a moderate interaction with Hsp90 has been found
before [37,74], but there were no reports on incorporation into SR
heterocomplexes. We reveal here the potential of XAP2 to interact
with SR. This leads to a differential impact on the transcriptional
activity of the receptors, with the strongest effects observed for GR
and PR, while MR displayed little reaction to the presence of
XAP2. XAP2 also interacts with other receptors, such as AhR
[74], peroxisome proliferator-activated receptor a [75] and
thyroid hormone receptor b1 [76]. These interactions go along
with an inhibition of the transcriptional activity of PPARa, and a
stimulation of AhR and THRb1. XAP2 also affects nuclear
translocation of AhR [77,78] and GR [37].
FKBP51 and FKBP52 are the most intensely investigated TPR
cofactors of steroid receptors. In particular for GR, important
insight was gained from experiments in yeast, that characterised
FKBP52 as stimulatory GR cofactor, while FKBP51 had no effect
[18]. Studies in mammalian cells reported a strong inhibitory
action of FKBP51 on GR, while over-expression of FKBP52 had
no effect [20,21,79,80]. In at least some mammalian cells, a
positive effect of FKBP52 on AR- and GR-signaling has been
observed [23,24,81]. Gene knock-out studies in mice revealed an
essential influence of FKBP52 on AR- and PR-related physiolog-
ical processes, while ablation of the FKBP51 gene did not result in
an overt phenotype [24–27]. Very recently, a stimulatory effect of
FKBP51 on AR has been reported in prostate cancer cells [82,83].
We have obtained preliminary evidence that this may be a cell-
type-specific effect (data not shown).
In the study presented here, FKBP51 and FKBP52 exhibited
divergent effects on the transcriptional activities of GR, MR, PR
and AR. Consistent with a previous report on GR [84], we also
observed a stronger incorporation of FKBP51 in SR hetero-
complexes than of FKBP52. At the same time, the interaction of
both proteins with Hsp90 was comparable. Thus, the interaction
with Hsp90 is not the sole determinant for the efficiency of
integration into SR-heterocomplexes. Our interaction analyses
further revealed a higher abundance of p23 in Hsp90 complexes
Figure 11. TPR cofactors differentially recruit components of the multichaperone heterocomplex. HEK cells were transfected and TPR
cofactors immunoprecipitated as described in the legends to figures 7–10. The relative amounts of the precipitated TPR cofactors, the co-precipitated
Hsp70 and Hsp90 were determined by densitometry of a coomassie stained gel of the eluates (A, upper panel), and the relative amount of p23 by
densitometry of the immunoblot signals (A, lower panel). B and D, quantification of the relative binding of co-precipitated Hsp90 (B) and Hsp70 (D).
Hsp90 signals and Hsp70 signals (only intensities above background binding were taken into consideration) were normalized to signals of the
respective precipitated TPR cofactors. Data are presented as relative binding + S.E.M. of at least 12 independent experiments with different steroid
receptors. C, quantification of the relative binding of co-precipitated p23. The p23 immunoblot signals were related (normalized) to the respective
TPR cofactor signal. Binding of p23 is presented relative to the mean of the normalized p23 eluate signals of the complete set of TPR-proteins.
doi:10.1371/journal.pone.0011717.g011
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be explained by the possibly different interaction surfaces of Hsp90
that are engaged in binding these two immunophilins. FKBP52, in
addition to the classic C-terminal MEEVD motif, recognises
amino acids at the ATP binding pocket [85], which may impinge
on p23 interaction. It should be noted, though, that binding of
FKBP51 to this N-terminal site has not been tested yet [85].
Whatever the explanation is for the differential recruitment of p23,
the increased presence of p23 may be related to the inhibitory
action of FKBP51 on GR [86]. In addition, the recruitment of
Hsp70 by FKBP51, albeit minor, could also add to the differential
action of FKBP51 and FKBP52, as Hsp70 is absent in mature
receptor heterocomplexes.
Our experiments revealed an inhibitory effect of PP5 that was
most pronounced in the case of GR. Previous studies examining
the effect of PP5 on GR produced partly inconsistent results.
Expression of the TPR domain of PP5 in CV-1 cells abolished
GR-dependent transcription [87], like probably the over-expres-
sion of any functional TPR-domain would do. On the other hand,
over-expression of the PP5 TPR domain slightly stimulated the
transactivation of ERa and ERb [31], which reinforces the notion
that the ERs differ in their TPR-protein dependency from the
other SRs. Expression of full-length PP5 inhibited ERa and ERb,
probably via dephosphorylation of ER [31]. Knock-down of PP5
increased GR-dependent reporter gene activity in one study [30],
while another study discovered a reduction of endogenous mRNA
levels of GR-dependent genes [32]. In yeast, no effect of PP5 on
GR was observed and PP5 was unable to compete with FKBP52
to decrease the GR-stimulation of this protein [18]. The inactivity
of PP5 in yeast, which is insufficiently endowed with TPR-
cofactors positive for GR, is compatible with our observations of
the inhibitory action of PP5 in mammalian cells. Another study in
yeast reported a positive effect of the PP5 yeast homologue Ppt1
on GR function, possibly due to removal of chaperone-inhibitory
phosphates on Hsp90 [33]. It is not known whether this seeming
discrepancy can be explained by differences between PP5 and its
yeast homologue Ppt1, or by differences in GR regulation between
yeast and mammalian cells in general.
The effects of the TPR proteins on SR observed here were
significantly attenuated by saturating concentrations of hormone.
This is consistent with an effect on hormone binding affinity.
Different laboratories including ours provided evidence that later
steps in steroid signal transduction are also affected by TPR
cofactors, for example nuclear translocation [21,88,89] and
dynamics of intranuclear mobility [90], which requires future
experiments to clarify their relative contributions. Our results
substantiate the concept that a delicate balance of TPR cofactors
governs SR activity in a given cell or tissue, probably in a
combinatorial fashion. The recent description of the N-terminal
FKBP52 binding site on Hsp90 [85] opens the possibility for
various combinations of two TPR proteins in the same SR
heterocomplex. Alternatively, the dynamic assembly and disas-
sembly of heterocomplexes may enable the sequential contribution
of specific functions by the different TPR proteins.
Materials and Methods
The MMTV-Luc reporter plasmid has been described previ-
ously [91]. ERE-Luc reporter plasmid and ERa and ERb cDNA
were a kind gift of Christian Behl (University Mainz). N-terminally
HA-tagged ERa and ERb were subcloned from ER cDNA into
the pRK5-SV40 backbone. The plasmids expressing the N-
terminally HA-tagged receptors GR, MR, PR and AR (pRK7
backbone) were kindly provided by Anke Hoffmann (MPI of
Psychiatry, Munich) and the plasmid expressing Hsp90-FLAG by
Len Neckers (NIH, Bethesda). The Gaussia-KDEL was construct-
ed from a pCMV-GaussiaLuc1 plasmid (PJK) by linking the
KDEL peptide sequence C-terminally via PCR, and subcloning
into pRK5-SV40 backbone. TPR-proteins were all expressed as
C-terminal FLAG-fusions in the pRK5-SV40 vector. The cDNA
of CHIP was provided by Cam Patterson (University of North
Carolina), of Cyp40 and TPR2 by Ulrich Hart (MPI of
Biochemistry, Martinsried), of PP5 by Michael Chinkers (Univer-
sity of South Alabama). The plasmids expressing the FKBP51 and
FKBP52 FLAG-fusions and the untagged FKBP52 in pRK5-
SV40 were described previously [21]. The XAP2 plasmid is
described in [37]. All plasmids were verified by sequencing. Primer
sequences and cloning details are available upon request.
Cell culture, transfection and reporter gene assay
Mouse embryonic fibroblasts (Marc Cox and David Smith,
Mayo Clinic Scottsdale, Arizona, USA), human neuroblastoma
SK-N-MC (ATTC HTB-10) and HEK-293 (ATTC CRL-1573)
cells were cultured under conditions described previously [92,93].
For the MMTV-luc reporter gene assay, cells were seeded in 96
well plates (SK-N-MC 30,000 cells/well; MEF 10,000 cells/well)
in medium containing 10% charcoal-stripped, steroid-free serum
and cultured for 24 h before transfection using ExGen (Fermentas)
as described by the manufacturer. Unless indicated otherwise, the
amounts of transfected plasmids per well were 60 ng of steroid
responsive luciferase reporter plasmid MMTV-Luc, 5–7.5 ng of
Gaussia-KDEL expression vector as control plasmid, 25 ng of
plasmids expressing HA-tagged steroid hormone receptors (mGR
in case of MEF cells) and up to 300 ng of plasmids expressing
TPR-domain containing cofactors (not exceeding 200 ng per
single TPR-protein expression plasmid). If needed, empty
expression vector was added to the reaction to equal the total
amount of plasmid in all transfections. 24 h after transfection, cells
were cultured in fresh medium supplemented with hormone as
indicated or ethanol as control for 24 h. To measure reporter gene
Figure 12. Loss of FKBP52 affects GR responsiveness to
cortisol. FKBP52-KO MEF cells (open symbols) or WT MEF cells (closed
circles) were transfected with the MMTV-Luc reporter plasmid, the
Gaussia-KDEL control plasmid, a plasmid expressing the HA-tagged
mGR and either a plasmid expressing FLAG-tagged FKBP52 (+ect.52) or
empty vector. After transfection, cells were cultivated for 24 h in the
presence of hormone. Relative receptor activity represents firefly data
normalized to Gaussia activities and is presented relative to the activity
at saturating 300 nM corticosterone +S.E.M. of three independent
experiments, each performed in triplicates. Significance of different
receptor activation between FKBP52 KO cells and FKBP52 KO cells
ectopically expressing FLAG-tagged FKBP52 was evaluated by one
sampled T-test (* denotes p-values #0.001).
doi:10.1371/journal.pone.0011717.g012
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lysis buffer (0.2% Triton X-100, 100 mM K2HPO4/KH2PO4
pH 7.8). Firefly and Gaussia luciferase activities were measured in
the same aliquot using an automatic luminometer equipped with
an injector device (Victor III, Wallac and Tristar, Berthold).
Firefly activity was measured first by adding 50 ml Firefly substrate
solution (3 mM MgCl2, 2.4 mM ATP, 120 mM D-Luciferin) to
10 ml lysate in black microtiter plates. By adding 50 ml Gaussia
substrate solution (1.1 M NaCl, 2.2 mM Na2EDTA, 0.22 M K2H
PO4/KH2PO4, pH 5.1, 0.44 mg/ml BSA, Coelenterazine 3 mg/
ml) the firefly reaction was quenched and Gaussia luminescence
was measured after a 5 s delay. Firefly activity data represent the
ratio of background corrected Firefly to Gaussia luminescence
values. The fold stimulation reached at saturating concentrations
of hormone was for GR about 1000, which is in the range of
previous publications [65,91], MR 3.7, PR 970, AR 6, ERa 4, and
ERb 6.3. To compare the effects of co-expressed TPR proteins,
the stimulation in the absence of the TPR protein was set to 100,
and the stimulation in the presence of co-expressed TPR protein
was referred to this value.
To check expression of receptors and TPR-proteins replicate
lysates were pooled, briefly sonicated and cleared by centrifuga-
tion. Alternatively receptors and TPR-proteins were coexpressed
in 6 well plates with the same receptor to TPR-protein ratios as for
the 96 well plates. To this end, SK-N-MC cells were seeded in 6
well plates (500,000 cells/well) in medium containing 10% steroid-
free serum and cultured for 24 before transfection of 0.25 mg HA-
tagged steroid hormone receptors and corresponding amounts of
plasmids expressing TPR-proteins per well using ExGen (Fermen-
tas) as described by the manufacturer. If needed, empty expression
vector was added to the reaction to equal the total amount of
plasmid in all transfections. Cells were cultured as for the reporter
gene assay and lysed in buffer containing 20 mM Tris-HCl
pH 6.8, 0.67% SDS, 3.3% Sacharose completed with Protease
Inhibitor Cocktail (Sigma), briefly sonicated and cleared by
centrifugation. Lysates were analyzed by SDS-PAGE followed
by immunoblot.
Statistical Analysis
To improve our understanding of the effects of various TPR
proteins on steroid receptor mediated gene transcription, we
performed one sample t-tests to evaluate the significance of
difference of the hormone-stimulated activity of the receptor in the
presence versus absence of coexpressed TPR protein. Significance
values were corrected according to the Bonferroni procedure. The
most pronounced differences with a significance level of p#0.001
are labelled in figures 3, 4 and 12 (*).
Immunoblot
Immunoblot detection of proteins was performed largely as
described [94]. Briefly, proteins were transferred from SDS gels to
a nitrocellulose membrane (Schleicher & Schuell, GmbH). Non-
specific binding to membrane was blocked by 5% nonfat milk in
Tris-buffered saline supplemented with 0.1% Tween-20, and then
one of the following specific primary antibodies were added: Actin
(I-19, Santa-Cruz), FLAG tag-HRP (M2, Sigma); hemagglutinin
tag-HRP (Roche Applied Science); p23 (ABR), FKBP52 (Anti-
FKBP59, Stressgen), CHIP (PC711, Calbiochem), Cyp40 (ABR,
PA3-022), FKBP51 (F14, Santa Cruz), XAP2 (ARA9, NB100-127,
Novus Biologicals), TPR2 (kind gift of Ulrich Hartl), PP5/PPT
(BD Biosciences). Signals were visualized by appropriate secondary
antibodies conjugated to horseradish peroxidase and the ECL
system (Millipore, Billerica, USA) and documented on X-ray film.
Immunoprecipitation
For immunoprecipitation of FLAG-tagged TPR proteins or
HA-tagged steroid receptors, HEK-293 cells were transfected with
2–10 mg of a plasmid expressing a TPR protein (amounts were
adjusted to ensure comparable expression levels) and 5 mgo fa
plasmid expressing a steroid receptor. For Hsp90 precipitations,
10 mg of FLAG-tagged Hsp90 expression plasmid were transfected
together with 10 mg of FKBP52 plasmid. HEK 293 cells were
chosen, because they efficiently expressed the proteins and showed
the same results in reporter gene assays as SK-N-MC cells.
Transfection was performed by electroporation of one confluent
10 cm (60 cm
2) dish (,5610
6 cells) using a GenePulser (Bio-Rad,
USA) at 350 V/700 mF in 400 ml of electroporation buffer
(50 mM K2HPO4/KH2PO4, 20 mM KAc, pH 7.35, 25 mM
MgSO4). Electroporated cells were replated in fresh medium
containing 10% steroid-free serum containing medium and
cultured for 3 days. Cells were harvested in cold PBS and lysed
by resuspension in Lysis-Buffer A9 (130 mM NaCl, 20 mM
Na2MoO4, 1 mM EDTA, 20 mM Tris-HCl pH 7.5, 10%
Glycerol, 0.5% Triton X-100, completed with Protease Inhibtor
cocktail, Sigma) for FLAG-TPR protein and receptor HA-IP, or in
Hsp90 Lysis Buffer (20 mM Tris-HCl pH 7.5, 50 mM NaCl,
20 mM Na2MoO4, 1 mM EDTA, 1 mM EGTA, 0.1% NP-40,
10% Glycerol, 0.5 mM DTT, completed with Protease Inhibitor
cocktail, Sigma and Phosphatase Inhibitor cocktail, Roche) for the
Hsp90 FLAG-IPs, followed by brief sonication (Branson Cell
Disruptor B15, 365 s, output 3) and incubation on ice for 1 h.
The lysate was cleared by centrifugation (10 min, 25.000 rcf, 4uC)
and the protein concentration was determined. 1–2 mg of lysate
was incubated overnight at 4uC with the anti-FLAG M2 agarose
affinity resin (Sigma) or with anti-HA agarose affinity resin
(Sigma), respectively. FLAG-beads (30 ml slurry) were treated as
recommended by the manufacturer. The next day, the beads were
washed 3 times with Lysis Buffer without detergent and samples
were eluted with 70 mlo f1 6FLAG-peptide solution (Sigma, 100–
200 mg/ml) or HA-peptide solution (Sigma, 100 mg/ml), respec-
tively, in 16 Tris-buffered saline (150 mM NaCl, 10 mM Tris-
HCl pH 7.0).
For analysis of the (co)precipitated proteins, 5–15 mg of the cell
lysates or 25 ml of the immunoprecipitates were separated by SDS-
PAGE under denaturing conditions. Coomassie staining was used
for detection of immunoprecipitated TPR-proteins and coimmu-
noprecipitated Hsp90 and Hsp70 in the FLAG-IP. For all other
detections immunoblots were used, i.e. the (co)precipitated steroid
receptors in the FLAG- and HA-IP, co-precipitated FLAG tagged
TPR-proteins in the HA-IP, and p23 in the FLAG-IP. To analyze
relative binding, the signals were subjected to densitometry. The
coomassie stained gels or films were scanned at 16 bit with a
calibrated densitometer (GS800, Bio-Rad, USA) and analyzed
with the Kodak 1D Image Analysis software.
To calculate the relative binding of co-precipitated proteins we
proceeded as follows: For relative binding of the receptors to the
precipitated TPR-proteins (FLAG-IP) the HA-immunoblot signals
of the eluates were first normalized with the Coomassie density
signals of the precipitated TPR proteins. To be able to compare
results between different experiments, we calculated these data to
represent relative receptor binding among the TPR proteins. To
this end, the normalized receptor (HA-IB) signal for each TPR
protein was divided by the mean of the normalized receptor
signals of all TPR proteins in each experiment. These ratios could
then be averaged throughout the different experiments.
Conversely, to calculate the relative binding of the associated
TPR proteins to the precipitated receptors (HA-IP), the FLAG-
immunoblot signals of the HA-IP eluates were normalized first
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for variations in precipitation efficiencies of the receptors), and
second to the FLAG-immunoblot signals of the lysate (to correct
for differences in TPR protein expression). To calculate the mean
of different experiments, like for the FLAG-IP, the normalized
signals of each TPR protein were represented in reference to the
relative binding of the other TPR proteins. Because of variabilities
of the HA-IPs, the relative binding of each TPR protein were not
normalized to the mean of all TPR proteins, but for each receptor
to the mean of a subset of TPR proteins. The subset of TPR
proteins used to calculate the mean binding in different
experiments are displayed in the figure legends of each receptor.
To analyze the relative binding of Hsp90, the Hsp90 (FLAG-
IP)- Coomassie signals were normalized to the Coomassie signals
of the precipitated TPR proteins and this relative binding was used
to calculate the mean binding in different experiments.
To analyze relative Hsp70 binding to TPR proteins (FLAG-IP),
first the Hsp70 signal of the control reaction (=background Hsp70
binding) was subtracted from the Hsp70 coomassie signals of each
TPR protein, and these values were then normalized to the
coomassie signals of the precipitated TPR proteins. Slightly
negative values were considered as no binding and set to zero.
This relative binding was used to calculate the mean binding in
different experiments. To analyze significant binding of Hsp70 to
FKBP51, a two tailed heteroscedastic students t-test were applied.
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